ArticleCureus2025
Early Sensory-Predominant Guillain-Barré Syndrome With Normal Cerebrospinal Fluid and MRI Findings: A Diagnostic Challenge.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Guillain-Barré Syndrome Emerging From Syringomyelia Management: A Case Report.Case reports in medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Guillain-Barré syndrome (GBS) is an acute, immune-mediated polyneuropathy that classically presents with progressive, symmetric weakness and areflexia following a preceding infection. However, early or atypical presentations may lack the hallmark diagnostic features, such as elevated cerebrospinal fluid (CSF) protein or abnormal magnetic resonance imaging (MRI) findings, creating a diagnostic challenge. We present the case of a 46-year-old woman who developed progressive distal paresthesias, gait instability, perioral numbness, hoarseness, and later right foot-drop following a viral-like illness. Initial evaluation revealed normal CSF protein levels, an unremarkable MRI of the brain and spine, and preserved strength, leading to diagnostic uncertainty. Despite these findings, the clinical pattern raised suspicion for early sensory-predominant GBS, and intravenous immunoglobulin therapy was initiated with subsequent clinical improvement. This case underscores the importance of maintaining high clinical suspicion for GBS in patients with compatible symptoms, even in the absence of classical diagnostic findings, to ensure timely intervention and prevent progression.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.